Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07735208 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Geriatric Assessment-Guided Treatment Selection in Older Adults With Acute Myeloid Leukemia

Study acronym: ALIGN-AML
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a phase 2 randomized controlled trial to evaluate whether a geriatric assessment (GA)-guided treatment strategy reduces treatment-related toxicity and improves patient-centered outcomes compared with usual oncologist-directed care in adults aged 60 years and older with newly diagnosed AML.
Trial Details
NCT Number NCT07735208
Lead Sponsor University of Rochester
Collaborators: Rising Tide Foundation
Conditions
(from sponsor)		 Acute Myeloid Leukemia
Related terms Leukemia, Myeloid, Acute
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov